Journals / MN Kardiyoloji / 2021 / Cilt: 28 - Sayı: 4

Inflammatory Parameters and Homocysteine Dilemma in Patients with Diabetes Mellitus Presenting with First Time Acute Coronary Syndrome

İlk Defa Akut Koroner Sendromla Başvuran Diabetes Mellituslu Hastalarda Enflamatuvar Parametreler ve Homosistein İkilemi

Pages
206–212
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the type‐2 diabetes mellitus group, hypertension rate (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim in this study was to investigate the role of serum inflammatory parameters in diabetes mellitus patients presenting for the first time with the acute coronary syndrome and to bring up the homocysteine debate.
📊
Key Findings & Data:Material and Method: A total of 228 patients who underwent coronary angiography with a diagnosis of the acute coronary syndrome were included in the study, 64 of them were patients with type‐2 diabetes mellitus, while 164 of them were the healthy control group.
💡
Conclusion & Impact:In the type‐2 diabetes mellitus group, hypertension rate (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Our aim in this study was to investigate the role of serum inflammatory parameters in diabetes mellitus patients presenting for the first time with the acute coronary syndrome and to bring up the homocysteine debate. Material and Method: A total of 228 patients who underwent coronary angiography with a diagnosis of the acute coronary syndrome were included in the study, 64 of them were patients with type‐2 diabetes mellitus, while 164 of them were the healthy control group. Patients were screened retrospectively and their demographic characteristics and laboratory findings were obtained from their medical records. Results: The mean age of the patients with type‐2 diabetes mellitus included in the study was (50,8±7,1 years), and that of the control group was (48,6±7,9 years). In the type‐2 diabetes mellitus group, hypertension rate (p

Özet

Amaç: Akut koroner sendrom ile ilk defa başvuran diabetes mellituslu hastalarda serumda enflamasyonu gösteren parametrelerin rolünü araştırmak ve homosistein tartışmasını gündeme getirmek. Gereç ve Yöntem: Çalışmaya akut koroner sendrom tanısı ile koroner anjiyografi uygulanan toplam 228 hasta alındı. Hastaların 64’ü tip 2 diabetes mellituslu iken, 164’ü tip 2 diabetes mellitus olmayan kontrol grubu idi. Hastalar geçmişe yönelik olarak tarandı ve medikal kayıtlarından demografik özellikleri ve laboratuvar bulguları bulundu. Bulgular: Çalışmaya alınan tip 2 diabetes mellituslu hastaların ortalama yaşı (50,8±7,1 yıl), kontrol grubunun ise (48,6±7,9 yıl) idi. Tip 2 diabetes mellitus hastalarında hipertansiyon oranı (p

🔖

Cite This Article

ÇETİN, Ş., ALTUNTAŞ, E., USALP, S., BAĞIRTAN, B., BAYRAKTAR, A., YÜCEL, E., ÇELEBİ, F., KARABAY, K. Ö., ÖZDEMİR, B. (2022). Inflammatory Parameters and Homocysteine Dilemma in Patients with Diabetes Mellitus Presenting with First Time Acute Coronary Syndrome. MN Kardiyoloji, Cilt: 28 - Sayı: 4, 206–212. https://ajindex.com/articles/581460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Virani SS. Alonso CA. Benjamin EJ. et al. Heart Disease and Stroke Statistics2020 Update: A Report from the American Heart Association. Circulation. 2020;141(9):139569
  2. Araujo GR. Nakagami H. Pathophysiology of cardiovascular disease in diabetes mellitus. Cardiovasc Endocrinol Metab. 2018;7(1):49
  3. Haffner SM. Diabetes, hyperlipidemia, and coronary artery disease. Am J ardiol. 1999;83(9B):1721
  4. Xu T. Chen S. Yang F. et al. The Impact of homocystein on the risk of coronary artery disease in individuals with diabetes: a Mendelian randomization study. Acta Diabetol. 2021;58(3)3:3017
  5. Roffi M. Patrono C. Collet JP. et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent STsegment elevation: Task Force for the Manage ment of Acute Coronary Syndromes in Patients Presenting without Persistent STSegment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267315
  6. Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology. 1967;89(5):81524
  7. Mitchell C. Rahko S. Blauwet LA. et al. Guidelines for Per for ming a Comprehensive Transthoracic Echocardiog raphic Examination in adults: Recommendation from the American Society of Echocardiography. J Am SocEchocardiogR. 2019;32(1):164
  8. Platt DE. Hariri E. Salameh P. et al. Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction. Diabetol Metab Syndr. 2017;9:19
  9. Mazza A. Bossone E. Mazza F. Distante A. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis. 2005;15(2):11824
  10. Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes. Biochem Soc Trans. 2007;35: 11759
  11. Tokgözoğlu L, Alikaşifoğlu M, Atalar E, et al. Homosistein ve MTHFR Genotipinin Koroner Arter Hastalığı Risk ve Yaygınlığının Belirlenmesindeki Önemi. Türk Kardiyol Dern Ars. 1999;27:598603
  12. Huang T, Ren J, Huang J&Dou Li. Association of homocysteine with type 2 diabetes: a metaanalysis implementing Mendelian randomization approach. BMC Genomics. 2013;14:867
  13. Ndrpepa G. Kastrati A. Braun S. et al. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. Clin Chim Acta. 2006;373(12): 706. 14. de Jagger J. Kooy A. Lehert P. et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomised place